BRANDI JONES: Open Payments
NPI 1356866842 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 40 payments from 13 companies in 2025. Trend: 2023 $842 · 2024 $778 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $316 |
| Lilly USA, LLC | 11 | $162 |
| ABBVIE INC. | 5 | $125 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Eisai Inc. | 1 | $24 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
| Electromed, Inc. | 1 | $18 |
Products named: Wegovy, MOUNJARO, Rybelsus, KISUNLA, VRAYLAR, UBRELVY, LEQVIO, Leqembi.
Industry payments across MI — which companies pay providers there.
